vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and FORRESTER RESEARCH, INC. (FORR). Click either name above to swap in a different company.
FORRESTER RESEARCH, INC. is the larger business by last-quarter revenue ($101.1M vs $90.3M, roughly 1.1× Evolus, Inc.). Evolus, Inc. runs the higher net margin — 0.1% vs -33.5%, a 33.7% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs -6.5%). Evolus, Inc. produced more free cash flow last quarter ($11.3M vs $-4.3M). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs 0.5%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
Forrester Research, Inc. is a research and advisory firm working in research, consulting and events. Forrester’s clients include large global business, technology and consumer enterprises. The firm is headquartered in Cambridge, MA.
EOLS vs FORR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.3M | $101.1M |
| Net Profit | $130.0K | $-33.9M |
| Gross Margin | 65.7% | 56.7% |
| Operating Margin | 4.7% | -36.6% |
| Net Margin | 0.1% | -33.5% |
| Revenue YoY | 14.4% | -6.5% |
| Net Profit YoY | 101.9% | -7941.4% |
| EPS (diluted) | $0.01 | $-1.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.3M | $101.1M | ||
| Q3 25 | $69.0M | $94.3M | ||
| Q2 25 | $69.4M | $111.7M | ||
| Q1 25 | $68.5M | $89.9M | ||
| Q4 24 | $78.9M | $108.0M | ||
| Q3 24 | $61.1M | $102.5M | ||
| Q2 24 | $66.9M | $121.8M | ||
| Q1 24 | $59.3M | $100.1M |
| Q4 25 | $130.0K | $-33.9M | ||
| Q3 25 | $-15.7M | $-2.1M | ||
| Q2 25 | $-17.1M | $3.9M | ||
| Q1 25 | $-18.9M | $-87.3M | ||
| Q4 24 | $-6.8M | $432.0K | ||
| Q3 24 | $-19.2M | $-5.8M | ||
| Q2 24 | $-11.3M | $6.3M | ||
| Q1 24 | $-13.1M | $-6.7M |
| Q4 25 | 65.7% | 56.7% | ||
| Q3 25 | 66.5% | 60.0% | ||
| Q2 25 | 65.3% | 55.5% | ||
| Q1 25 | 68.1% | 55.9% | ||
| Q4 24 | 66.7% | 58.8% | ||
| Q3 24 | 68.9% | 60.5% | ||
| Q2 24 | 70.3% | 57.3% | ||
| Q1 24 | 68.3% | 54.9% |
| Q4 25 | 4.7% | -36.6% | ||
| Q3 25 | -16.7% | 4.7% | ||
| Q2 25 | -14.7% | 6.2% | ||
| Q1 25 | -22.1% | -97.5% | ||
| Q4 24 | -2.9% | -0.5% | ||
| Q3 24 | -25.3% | -0.7% | ||
| Q2 24 | -11.5% | 9.3% | ||
| Q1 24 | -15.0% | -9.3% |
| Q4 25 | 0.1% | -33.5% | ||
| Q3 25 | -22.8% | -2.3% | ||
| Q2 25 | -24.7% | 3.5% | ||
| Q1 25 | -27.6% | -97.1% | ||
| Q4 24 | -8.6% | 0.4% | ||
| Q3 24 | -31.4% | -5.7% | ||
| Q2 24 | -17.0% | 5.2% | ||
| Q1 24 | -22.1% | -6.7% |
| Q4 25 | $0.01 | $-1.75 | ||
| Q3 25 | $-0.24 | $-0.11 | ||
| Q2 25 | $-0.27 | $0.20 | ||
| Q1 25 | $-0.30 | $-4.62 | ||
| Q4 24 | $-0.11 | $0.02 | ||
| Q3 24 | $-0.30 | $-0.30 | ||
| Q2 24 | $-0.18 | $0.33 | ||
| Q1 24 | $-0.22 | $-0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.8M | $63.3M |
| Total DebtLower is stronger | $146.1M | — |
| Stockholders' EquityBook value | $-23.1M | $126.5M |
| Total Assets | $225.9M | $404.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.8M | $63.3M | ||
| Q3 25 | $43.5M | $65.1M | ||
| Q2 25 | $61.7M | $67.8M | ||
| Q1 25 | $67.9M | $75.6M | ||
| Q4 24 | $87.0M | $56.1M | ||
| Q3 24 | $85.0M | $62.8M | ||
| Q2 24 | $93.7M | $58.9M | ||
| Q1 24 | $97.0M | $61.4M |
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $120.9M | — | ||
| Q1 24 | $120.6M | — |
| Q4 25 | $-23.1M | $126.5M | ||
| Q3 25 | $-28.8M | $157.7M | ||
| Q2 25 | $-18.7M | $159.5M | ||
| Q1 25 | $-6.6M | $147.4M | ||
| Q4 24 | $5.5M | $229.5M | ||
| Q3 24 | $5.9M | $234.3M | ||
| Q2 24 | $19.3M | $237.1M | ||
| Q1 24 | $18.4M | $230.9M |
| Q4 25 | $225.9M | $404.0M | ||
| Q3 25 | $219.0M | $414.2M | ||
| Q2 25 | $228.8M | $436.0M | ||
| Q1 25 | $213.4M | $439.8M | ||
| Q4 24 | $232.6M | $503.9M | ||
| Q3 24 | $229.6M | $505.3M | ||
| Q2 24 | $233.8M | $524.2M | ||
| Q1 24 | $226.2M | $555.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — | ||
| Q1 24 | 6.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.8M | $-3.2M |
| Free Cash FlowOCF − Capex | $11.3M | $-4.3M |
| FCF MarginFCF / Revenue | 12.6% | -4.2% |
| Capex IntensityCapex / Revenue | 1.6% | 1.1% |
| Cash ConversionOCF / Net Profit | 98.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.7M | $18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.8M | $-3.2M | ||
| Q3 25 | $-14.7M | $1.2M | ||
| Q2 25 | $-24.8M | $-3.6M | ||
| Q1 25 | $-15.6M | $26.7M | ||
| Q4 24 | $4.8M | $-1.8M | ||
| Q3 24 | $-5.7M | $264.0K | ||
| Q2 24 | $-6.5M | $-2.9M | ||
| Q1 24 | $-10.6M | $611.0K |
| Q4 25 | $11.3M | $-4.3M | ||
| Q3 25 | $-15.6M | $524.0K | ||
| Q2 25 | $-25.5M | $-4.2M | ||
| Q1 25 | $-16.0M | $26.1M | ||
| Q4 24 | $4.4M | $-2.5M | ||
| Q3 24 | $-6.0M | $-223.0K | ||
| Q2 24 | $-6.9M | $-3.7M | ||
| Q1 24 | $-10.9M | $-815.0K |
| Q4 25 | 12.6% | -4.2% | ||
| Q3 25 | -22.7% | 0.6% | ||
| Q2 25 | -36.7% | -3.8% | ||
| Q1 25 | -23.3% | 29.0% | ||
| Q4 24 | 5.5% | -2.3% | ||
| Q3 24 | -9.9% | -0.2% | ||
| Q2 24 | -10.4% | -3.1% | ||
| Q1 24 | -18.3% | -0.8% |
| Q4 25 | 1.6% | 1.1% | ||
| Q3 25 | 1.4% | 0.7% | ||
| Q2 25 | 1.0% | 0.5% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.6% | 0.6% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 0.7% | 0.7% | ||
| Q1 24 | 0.4% | 1.4% |
| Q4 25 | 98.67× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.93× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -4.24× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.46× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
Segment breakdown not available.
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
